SM
Starling Medical, Inc.
SEC filingBiotechnology · Houston, TX
Amount raised$825Ksold at filing
Total offering$1.8M$925K still open
Investors in the raise5count reported to the SEC
FiledMar 19, 2026first sale Feb 27, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
William Andrew HendricksDirector
Hannah Andrew McKenneyExecutive Officer, Director
Kunj Andrew ShethDirector
Shana Andrew BarghoutiDirector
William Andrew HagamanDirector
Executive officers, directors and promoters as listed on the Form D.